Urkon, M.; Ferencz, E.; Szász, J.A.; Szabo, M.I.M.; Orbán-Kis, K.; Szatmári, S.; Nagy, E.E.
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease. Pharmaceuticals 2025, 18, 614.
https://doi.org/10.3390/ph18050614
AMA Style
Urkon M, Ferencz E, Szász JA, Szabo MIM, Orbán-Kis K, Szatmári S, Nagy EE.
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease. Pharmaceuticals. 2025; 18(5):614.
https://doi.org/10.3390/ph18050614
Chicago/Turabian Style
Urkon, Melinda, Elek Ferencz, József Attila Szász, Monica Iudita Maria Szabo, Károly Orbán-Kis, Szabolcs Szatmári, and Előd Ernő Nagy.
2025. "Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease" Pharmaceuticals 18, no. 5: 614.
https://doi.org/10.3390/ph18050614
APA Style
Urkon, M., Ferencz, E., Szász, J. A., Szabo, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E.
(2025). Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease. Pharmaceuticals, 18(5), 614.
https://doi.org/10.3390/ph18050614